FDANews
FDAnews Device Daily Bulletin

FTC Charges Settled with Aura Labs on Blood Pressure Reading App Accuracy

Dec. 13, 2016

Aura Labs has settled allegations of false marketing for their blood pressure reading app with the FTC.

Aura Labs marketed their app claiming that it could be “used to replace around-the-arm cuffs and would be just as accurate as the traditional device” the FTC said.

The court order prohibits Aura Labs from making unsupported claims for future products and the company must disclose any material relations between Aura and its supporters.

The company was fined $595,945, but the fine was suspended based on their inability to pay. — Cynthia Jessup

View today's stories